Working together

CAMH has a tremendous responsibility to the people who turn to us for care. We know meaningful recovery is within reach, and that we cannot stop now.

From left to right: Kelly E.D. Meighen, Dr. Catherine Zahn, Darrell Louise Gregersen, and Ana P. Lopes

The challenges are formidable. We don’t yet fully understand what causes mental illness or how to prevent it. Treatments are effective but don’t work for everyone, and many people with mental illness struggle to access the services they need. Their health deteriorates with every roadblock or detour.

But while the need is great, our commitment is greater. We are serving more patients at CAMH, while increasing the capacity of care providers across Ontario to care for patients in their local communities. We know we cannot afford to let even one person fall through the cracks.

In our Campbell Family Mental Health Research Institute, our scientists are identifying the biomarkers needed for a greater understanding of what causes mental illness. They are piloting personalized medicine, where a simple cheek swab identifies the right medication for the right patient. This signals the end of trial-and-error prescribing, and sets people on the path to recovery sooner.

We are pioneering new treatments with enormous potential. Brain stimulation, for example, is painless and effective with virtually no side-effects—the most significant advance in mental health treatment in more than a generation.

This year we made major discoveries that bring us closer to understanding what causes schizophrenia. We are pinpointing new targets for treatment, and sharing those targets with the world.

Our impact extends beyond science. We are helping build a better system to help more people access the right care at the right time. We are tackling the social factors that determine mental health, and are challenging the prejudice and stigma that prevents so many from getting the help they need. By reducing stigma, we know we will stop mental illness from destroying lives.

Our ability to create positive change will continue to grow because our work is supported by people with vision—true leaders in the quest to build a society in which everyone believes life is worth living. Private philanthropy has been central to our success.

Through our Breakthrough Campaign, philanthropic leaders are generating the resources needed to have a powerful impact in the lives of people with mental illness. They are helping us turn groundbreaking research into life-saving treatments, and enabling us to create modern spaces that promote healing and recovery. We have reached an exciting milestone in the Breakthrough Campaign—$125 million on our $200-million goal—the largest-ever campaign for mental health in Canada.

The breakthroughs have already begun at CAMH and there are many more to come.

Dr. Catherine Zahn Dr. Catherine Zahn

Dr. Catherine Zahn President & CEO,
CAMH

Darrell Louise Gregersen Darrell Louise Gregersen

Darrell Louise Gregersen President & CEO,
CAMH Foundation

Kelly E. D. Meighen Kelly E. D. Meighen

Kelly E. D. MeighenChair,
CAMH

Ana P. Lopes Ana P. Lopes

Ana P. LopesChair,
CAMH Foundation


Share this: